Peptides and Longevity: A Clear-Eyed Look at the Anti-Aging Pitch

The longevity pitch for peptides usually goes like this: a molecule your body makes less of as you age, a mouse that lived longer or ran farther, and a monthly plan to "turn back the clock." Each piece can be technically true while the conclusion is not. If you're interested in aging well, and most of us are, it's worth knowing exactly where the evidence ends.

This is not an argument that aging research is hype. It is one of the most interesting fields in biology. The problem is the gap between what that research has found and what is being sold today, often at several hundred dollars a month.

Why "anti-aging" isn't an approved use

FDA approves drugs to diagnose, treat or prevent specific diseases or conditions, based on trials that measure specific outcomes. Aging is not currently an approved indication, which means no company has had a drug approved on the basis that it slows aging in general. When a product is marketed as anti-aging, that claim has not been through FDA review.

This matters because it tells you what kind of evidence could, in principle, back a longevity claim. It would take long human trials showing fewer age-related diseases, less disability, or longer life, compared with a control group. Those trials are slow and expensive, and for the peptides sold as longevity treatments they have not been done.

The growth hormone precedent

Growth hormone is the clearest case study because it was tested. Interest took off after a small 1990 study by Rudman and colleagues in the New England Journal of Medicine reported changes in lean mass and fat in men over 60 who received growth hormone injections. Anti-aging clinics built businesses on it.

When researchers later pooled the controlled trials, the picture was less exciting. A systematic review by Liu and colleagues (Annals of Internal Medicine, 2007) analyzed 18 randomized trials involving 508 healthy older adults, with a mean age of 68. Growth hormone produced a small reduction in fat mass and a small increase in lean body mass, around 2 kilograms each. Participants receiving it had higher rates of soft-tissue swelling, joint pain, carpal tunnel syndrome and breast tissue enlargement in men, and were more likely to develop glucose problems. The authors concluded that growth hormone cannot be recommended as an anti-aging therapy.

That history is directly relevant to the peptides marketed today as "natural" ways to raise growth hormone, such as sermorelin, CJC-1295 and ipamorelin. If raising growth hormone directly didn't deliver the anti-aging benefits people hoped for in controlled trials, a peptide that nudges your body to release more of it has a lot to prove. Our explainer on CJC-1295 and ipamorelin covers the specifics.

The longevity peptides, one by one

Epitalon

Epitalon is a four-amino-acid synthetic peptide developed in St. Petersburg. Laboratory work from the developing group reported telomerase activity and telomere elongation in human fetal cells, and a 2003 mouse study (Anisimov and colleagues, Biogerontology) reported a 12.3% increase in maximum lifespan with no significant change in mean lifespan. Most of the research comes from one institution, and independent human trials showing longer or healthier life are lacking. We cover it in depth in epitalon and the telomere claims.

MOTS-c

MOTS-c is a peptide encoded in mitochondrial DNA. In a 2021 study in Nature Communications, Reynolds and colleagues reported that MOTS-c treatment improved physical performance in young, middle-aged and old mice, and that late-life treatment increased physical capacity and healthspan measures in mice. The authors also found that exercise raised MOTS-c levels in human muscle and blood. What the study did not show is that giving MOTS-c to people does anything similar, and the trend toward longer lifespan in treated mice was not statistically significant. More in our MOTS-c explainer.

GHK-Cu

GHK-Cu is a copper-binding peptide with a reasonable body of skin and wound-healing research, much of it laboratory and topical. The leap from "used in skin creams" to "systemic anti-aging injection" is large and unsupported by human trials.

BPC-157 and TB-500

These are usually sold for recovery rather than longevity, but they often appear in "healthspan" packages. Their evidence is mostly animal studies, and FDA reviewers described the BPC-157 human studies as short, small and insufficient to establish safety or effectiveness.

Where the law stands

None of the longevity peptides above is FDA-approved. At the July 2026 Pharmacy Compounding Advisory Committee meeting, panelists narrowly voted to recommend epitalon and MOTS-c, among others, for the 503A bulks list, even though FDA's own reviewers had concluded none of the seven substances met the criteria. The votes are non-binding; adding a substance requires rulemaking, and no final rule has been reported as of this writing. GHK-Cu is scheduled for a further committee review expected in February 2027. Rules change; verify with FDA. If you compete in a tested sport, check any peptide with USADA or your anti-doping organization first, because many fall under the World Anti-Doping Agency Prohibited List. The details of the vote are in the July 2026 peptide vote, explained.

What approved peptide medicines can honestly claim

Here the story is more encouraging, and more specific. Several approved peptide drugs reduce the risk of conditions that become more common with age, in the patients they were tested in:

• Semaglutide (Wegovy) is approved to reduce the risk of major cardiovascular events in adults with established cardiovascular disease and obesity or overweight, as well as for weight reduction.
• Teriparatide and abaloparatide are approved to treat osteoporosis in people at high risk of fracture.
• Insulin and GLP-1 medicines treat diabetes, which drives many age-related complications.

None of these is an anti-aging drug. Each treats a defined condition, with known risks, in people who meet specific criteria. That's what a medicine that genuinely affects health in later life tends to look like. Our overview of FDA-approved peptide medicines goes through the list.

What has the strongest evidence for aging well

It's less exciting to sell, but the list of things with strong human evidence for longer, healthier life is well established:

1. Regular physical activity, including strength training, which matters more with every decade.
2. Not smoking, and keeping alcohol low.
3. Blood pressure, cholesterol and blood sugar managed to evidence-based targets.
4. Sleep, including screening for sleep apnea.
5. Recommended cancer screenings and vaccinations.
6. Treating depression, hearing loss and social isolation, which are linked with poorer outcomes in later life.

If a longevity plan doesn't include most of these, it isn't really a longevity plan. It's a product.

Questions to ask a longevity clinic

• Which of these products is FDA-approved, and for what?
• What human trial evidence, not animal data, supports this use in someone like me?
• What is the legal basis for dispensing it today, and which licensed pharmacy prepares it?
• What outcomes will we measure, and what result would make us stop?
• Are the "biological age" tests you use validated for guiding treatment decisions?

Where a clinician fits

Interest in aging well is a good reason to see a clinician. It just isn't, on its own, a good reason to start an unapproved injection. A useful consultation looks at your actual risks: family history, blood pressure, lipids, glucose, bone health, weight, sleep, hormones where symptoms warrant it. Then it matches you to interventions with evidence behind them, which sometimes include approved peptide medicines.

The same logic applies to hormones: testosterone treats a diagnosed deficiency, not aging, as we explain in why TRT is not anti-aging. Matching people to evidence, not to products, is how we run our peptide therapy consultations. If a peptide doesn't fit your goals or your risk profile, we'll say so. If you want an honest, individualized look at your options, book a consultation.

Common questions

Is there any peptide proven to slow aging?

No. No peptide has been shown in human trials to slow aging or extend lifespan, and no drug is FDA-approved for that purpose.

Do growth hormone peptides reverse aging?

There's no good evidence that they do. Trials of growth hormone itself in healthy older adults found small body-composition changes, more side effects, and no basis for recommending it as an anti-aging therapy.

Are longevity peptides safe to try?

For most, the honest answer is that their safety in long-term human use hasn't been established. That's different from being known to be harmful, but it isn't a reason for confidence either.

Why do longevity clinics use mouse studies?

Because for most longevity peptides, animal studies are the strongest evidence available. They're a legitimate basis for further research, not for routine treatment.